Pneumonia News and Research

Latest Pneumonia News and Research

UVA scientists’ efforts could help better combat antibiotic-resistant bacteria

University of Virginia researchers are working to outrace two dangerous germs known for quickly developing resistance to new antibiotics – and the scientists’ efforts could help us better combat antibiotic resistance more broadly.

12 Oct 2023

UVA researchers take on antibiotic resistance crisis with $1.2 million grant

University of Virginia researchers are working to outrace two dangerous germs known for quickly developing resistance to new antibiotics – and the scientists' efforts could help us better combat antibiotic resistance more broadly.

10 Oct 2023

Comparing the lasting effects: post COVID vs. non-COVID acute respiratory infections

Symptom profiles between individuals with prior COVID-19 and those with other acute respiratory infections (ARIs).

10 Oct 2023

RSV in seniors: Less common than COVID-19, but hits harder, CDC study reveals

In a recent CDC's MMWR study, researchers found that while respiratory syncytial virus (RSV) infections are less common than COVID-19 and influenza in Americans aged 60+ years, they result in much more severe clinical outcomes. This insight supports the CDC's recommendation for RSV vaccination in older adults, emphasizing its potential in preventing severe respiratory disease.

10 Oct 2023

People may experience 'long colds' after acute respiratory infections, study finds

A new study from Queen Mary University of London, published in The Lancet's EClinicalMedicine, has found that people may experience long-term symptoms -;or 'long colds'-;after acute respiratory infections that test negative for COVID-19.

6 Oct 2023

Inhaled nitric oxide shows promise as treatment for COVID-19 respiratory failure

Inhaled nitric oxide gas widens blood vessels in the lungs and is used to treat severe cardio-pulmonary conditions in newborns and adults.

6 Oct 2023

USC-led team develops vaccine to boost immune system against superbugs

What if a vaccine, given to patients just before or after arriving at the hospital, could protect them against lethal superbugs that lurk in healthcare settings?

5 Oct 2023

New meningitis vaccine safe and effective for infants in Africa

University of Maryland School of Medicine (UMSOM) researchers, as part of the Infectious Diseases Clinical Research Consortium (IDCRC), provided an interim analysis showing that the pentavalent (NmCV-5) meningitis vaccine is safe for use in 9-month-old infants in the meningitis belt of sub-Saharan Africa.

3 Oct 2023

Promising potential of probiotics and their byproducts for targeting antibiotic-resistant bacteria

The use of probiotics and antimicrobial peptides (AMPs) against multi-drug-resistant (MDR) bacteria.

27 Sep 2023

Early feeding practices key to shaping lifelong oral microbiome

Research delves into the little-explored world of the infant oral microbiome, examining how early nutrition and environmental factors shape it. With implications for lifelong health, the research aims to guide future health recommendations, emphasizing the need for more longitudinal studies and advanced sequencing techniques.

26 Sep 2023

Long COVID research plagued by flawed methods, say experts

Overly broad definitions, a lack of appropriate, or any, comparison groups, among other things, in studies looking at the incidence, prevalence, and control of the condition-;epidemiology-;have distorted the risks, say the researchers.

25 Sep 2023

One gene variant could be a shield against severe COVID-19 lung damage

Researchers identify a specific genetic variant, rs2204985, linked to less severe lung involvement and a stronger immune response in COVID-19 patients with severe pneumonia. The study suggests that understanding this genetic marker could help identify high-risk individuals and enhance strategies for prevention and treatment.

25 Sep 2023

Omics analysis identifies new biomarkers for predicting mortality in patients with pneumonia

Community-acquired pneumonia (CAP) is a major infectious disease worldwide and contributes to high mortality and massive economic burden. Hospital mortality among the severe CAP (SCAP) remains high, ranging from 25% to more than 50%.

22 Sep 2023

Cough analysis as a tool to predict severe pneumonia in COVID-19 patients

While most individuals impacted by COVID-19 experience milder symptoms and recover within a few weeks, the global pandemic caused by the SARS-CoV-2 virus continues to pose a significant health challenge.

21 Sep 2023

American Thoracic Society partners with five new health systems to improve vaccination rates

As cities brace for a confluence of flu, COVID-19, pneumonia, and RSV infections this fall, the American Thoracic Society announced that five new health systems have partnered with the Society to improve vaccination rates.

20 Sep 2023

Nanoparticle gene delivery system shows promise for treating ARDS

Discovery from the lab of Youyang Zhao, PhD, from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago offers promising treatment approaches for acute respiratory distress syndrome (ARDS) in the elderly that can be caused by severe COVID-19, pneumonia, flu or sepsis. Currently there are no pharmacological or cell-based treatments for ARDS.

19 Sep 2023

Bacteriophage cocktail can effectively disrupt Klebsiella pneumoniae biofilms on medical equipment

Researchers investigated whether a cocktail of bacteriophages coding for the depolymerase polysaccharide could effectively disrupt Klebsiella pneumoniae biofilms.

18 Sep 2023

Microbiome composition influences severity of Legionnaires' disease

Pneumonia is an infection of the lung alveoli caused by bacteria, viruses or fungi. It is one of the leading causes of morbidity and mortality worldwide, representing a clinical and economic burden and a global public health problem.

13 Sep 2023

CDC recommendations for pneumococcal vaccine in adults

Updated recommendations from the CDC on the use of pneumococcal vaccines in adults in the United States.

12 Sep 2023

COPD hospitalizations rising sharply in Canada, especially among younger females

Annual hospital admissions for chronic obstructive pulmonary disease (COPD) in Canada increased 69% since 2002, especially in females and people under age 65, according to new research in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221051.

11 Sep 2023

Pneumonia News and Research

Latest Pneumonia News and Research

UVA scientists’ efforts could help better combat antibiotic-resistant bacteria

UVA researchers take on antibiotic resistance crisis with $1.2 million grant

Comparing the lasting effects: post COVID vs. non-COVID acute respiratory infections

RSV in seniors: Less common than COVID-19, but hits harder, CDC study reveals

People may experience 'long colds' after acute respiratory infections, study finds

Inhaled nitric oxide shows promise as treatment for COVID-19 respiratory failure

USC-led team develops vaccine to boost immune system against superbugs

New meningitis vaccine safe and effective for infants in Africa

Promising potential of probiotics and their byproducts for targeting antibiotic-resistant bacteria

Early feeding practices key to shaping lifelong oral microbiome

Long COVID research plagued by flawed methods, say experts

One gene variant could be a shield against severe COVID-19 lung damage

Omics analysis identifies new biomarkers for predicting mortality in patients with pneumonia

Cough analysis as a tool to predict severe pneumonia in COVID-19 patients

American Thoracic Society partners with five new health systems to improve vaccination rates

Nanoparticle gene delivery system shows promise for treating ARDS

Bacteriophage cocktail can effectively disrupt Klebsiella pneumoniae biofilms on medical equipment

Microbiome composition influences severity of Legionnaires' disease

CDC recommendations for pneumococcal vaccine in adults

COPD hospitalizations rising sharply in Canada, especially among younger females

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Pneumonia News and Research

Latest Pneumonia News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in